Correlation Between Salmon Evolution and PCI Biotech
Can any of the company-specific risk be diversified away by investing in both Salmon Evolution and PCI Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salmon Evolution and PCI Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salmon Evolution Holding and PCI Biotech Holding, you can compare the effects of market volatilities on Salmon Evolution and PCI Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salmon Evolution with a short position of PCI Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salmon Evolution and PCI Biotech.
Diversification Opportunities for Salmon Evolution and PCI Biotech
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Salmon and PCI is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Salmon Evolution Holding and PCI Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCI Biotech Holding and Salmon Evolution is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salmon Evolution Holding are associated (or correlated) with PCI Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCI Biotech Holding has no effect on the direction of Salmon Evolution i.e., Salmon Evolution and PCI Biotech go up and down completely randomly.
Pair Corralation between Salmon Evolution and PCI Biotech
Assuming the 90 days trading horizon Salmon Evolution Holding is expected to under-perform the PCI Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Salmon Evolution Holding is 5.92 times less risky than PCI Biotech. The stock trades about -0.07 of its potential returns per unit of risk. The PCI Biotech Holding is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 159.00 in PCI Biotech Holding on August 30, 2024 and sell it today you would earn a total of 5.00 from holding PCI Biotech Holding or generate 3.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salmon Evolution Holding vs. PCI Biotech Holding
Performance |
| Timeline |
| Salmon Evolution Holding |
| PCI Biotech Holding |
Salmon Evolution and PCI Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salmon Evolution and PCI Biotech
The main advantage of trading using opposite Salmon Evolution and PCI Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salmon Evolution position performs unexpectedly, PCI Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PCI Biotech will offset losses from the drop in PCI Biotech's long position.| Salmon Evolution vs. Sparebanken Ost | Salmon Evolution vs. Clean Seas Seafood | Salmon Evolution vs. 5Th Planet Games | Salmon Evolution vs. Gaming Innovation Group |
| PCI Biotech vs. AutoStore Holdings | PCI Biotech vs. Arcticzymes Technologies ASA | PCI Biotech vs. ContextVision AB | PCI Biotech vs. Airthings ASA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |